832103-01-2 Usage
Uses
Used in Pharmaceutical Industry:
5-amino-N,N-dimethyl-1-benzothiophene-2-carboxamide is used as a potential pharmaceutical compound for its unique structure that may offer specific biological activities. The presence of the amino and carboxamide groups could allow for interactions with biological targets, making it a candidate for drug development.
Used in Agrochemical Industry:
In the agrochemical sector, 5-amino-N,N-dimethyl-1-benzothiophene-2-carboxamide may serve as a precursor or active ingredient in the development of new pesticides or herbicides. Its chemical structure could provide novel modes of action against pests or weeds, contributing to more effective and targeted agricultural solutions.
Note: The specific applications and reasons for use provided here are speculative based on the general properties of benzothiophene derivatives and carboxamides. Actual applications would depend on the results of further research and development, including biological testing and safety assessments.
Check Digit Verification of cas no
The CAS Registry Mumber 832103-01-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,2,1,0 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 832103-01:
(8*8)+(7*3)+(6*2)+(5*1)+(4*0)+(3*3)+(2*0)+(1*1)=112
112 % 10 = 2
So 832103-01-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N2OS/c1-13(2)11(14)10-6-7-5-8(12)3-4-9(7)15-10/h3-6H,12H2,1-2H3
832103-01-2Relevant academic research and scientific papers
6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist
Tavares, Francis X.,Al-Barazanji, Kamal A.,Bishop, Michael J.,Britt, Christy S.,Carlton, David L.,Cooper, Joel P.,Feldman, Paul L.,Garrido, Dulce M.,Goetz, Aaron S.,Grizzle, Mary K.,Hertzog, Donald L.,Ignar, Diane M.,Lang, Daniel G.,McIntyre, Maggie S.,Ott, Ronda J.,Peat, Andrew J.,Zhou, Hui-Qiang
, p. 7108 - 7118 (2011/05/18)
Genetic manipulation studies in mice at both the MCH receptor 1 (MCHR1) as well as the MCH peptide levels have implicated MCHR1 as a key player in energy homeostasis. The phenotype exhibited by these studies, that is, increased metabolic rate, resistance to high fat diet, and subsequent weight loss, has spurred considerable efforts to develop antagonists of MCHR1. In continuation of efforts directed toward this goal, the present work capitalizes on the putative binding mode of an MCH antagonist, resulting in the identification of several novel chemotypes that are potent and selective MCHR1 antagonists. In addition, the favorable pharmacokinetics of representative examples has allowed for the evaluation of an MCHR1 antagonist in a high fat diet-induced obese rodent model of obesity. The tolerability of the right-hand side of the template for diverse chemotypes accompanied by favorable effects on weight loss enhances the attractiveness of this template in the pursuit toward development of effective anti-obesity agents.
